Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intellia Thera CS (NQ: NTLA )

23.60 +0.33 (+1.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,294,988
Open 24.44
Bid (Size) 23.12 (3)
Ask (Size) 24.45 (2)
Prev. Close 23.27
Today's Range 23.42 - 24.99
52wk Range 19.37 - 47.48
Shares Outstanding 88,140,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines. 
Via InvestorPlace
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion. 
Via InvestorPlace

Performance

YTD
-23.43%
-23.43%
1 Month
-5.49%
-5.49%
3 Month
-4.99%
-4.99%
6 Month
-14.68%
-14.68%
1 Year
-46.24%
-46.24%

More News

Read More
2 Stocks Down 30% to Buy Right Now
Via The Motley Fool
Cathie Wood Goes Bargain Hunting. 2 Stocks She Bought This Week.
Via The Motley Fool
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
Via The Motley Fool
Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm
Via News Direct
Is Intellia Therapeutics Stock a Buy Now?
Via The Motley Fool
A Preview Of Intellia Therapeutics's Earnings
Via Benzinga
ARKK’s Tech Bets: Over 500k Roblox Shares Purchased, 1.24M Robinhood Shares Sold
Via Talk Markets
Topics ETFs
Better Cathie Wood Stock: Moderna vs. Intellia
Via The Motley Fool
Hot Stocks: The 3 Best Opportunities for Investing in Biotech
Via InvestorPlace
3 Stocks That Could Be the Next Big Thing in Gene Editing
Via InvestorPlace
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst
Via The Motley Fool
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
Via The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
Via Benzinga
Is CRISPR Therapeutics the NVIDIA of gene editing?
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Earnings Scheduled For February 22, 2024
Via Benzinga
Cathie Wood Is Betting on This Top Technology: 2 Stocks She Just Bought
Via The Motley Fool
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential
Via InvestorPlace
Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen?
Via The Motley Fool
Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
From ReCode Therapeutics
Via Business Wire
Analysts see over 50% gains in these 2 mid-cap biotech stocks
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
3 Gene Editing Stocks With Unprecedented Surge Potential
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in February 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.